Study #2012-1157
Detection and Characterization of Benign and Malignant Liver Lesions in Contrast-enhanced MRI
MD Anderson Study Status
Not Accepting
Treatment Agent
Gadobutrol, Gadoxetate Disodium
Description
This clinical trial studies contrast-enhanced magnetic resonance imaging (MRI) in detecting nonmalignant and malignant liver lesions. Diagnostic procedures, such as MRI, may help find and diagnose nonmalignant and malignant liver lesions. Contrast agents, such as gadoxetate disodium and gadobutrol, may help doctors to see MRI images more clearly.
Resources and Links
Phone Number: 1-877-MDA-6789
Information and next steps
Disease:
Hepatocellular Carcinoma, Liver and Intrahepatic Bile Duct Disorder, Metastatic Malignant Neoplasm in the Liver, Primary Malignant Liver Neoplasm
Study phase:
Not applicable
Physician name:
Janio Szklaruk
Department:
Diagnostic Radiology
For general questions about clinical trials:
1-855-981-0775
Help #EndCancer
Give Now
Donate Blood
Our patients depend on blood and platelet donations.
Shop MD Anderson
Show your support for our mission through branded merchandise.